Evidence map›Paper›PMID 38384390›Full record

ArticleJournal of mood and anxiety disorders2023

A randomized clinical trial of behavioral activation and exposure-based therapy for adults with generalized anxiety disorder.

Hannah Berg, Elisabeth Akeman, Timothy J McDermott, Kelly T Cosgrove, Namik Kirlic, Ashley Clausen, Mallory Cannon, Hung-Wen Yeh, Evan White, Wesley K Thompson and 10 more

Erratum issued Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of mood and anxiety disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02807480 (Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02807480 nacompletednot on this map

Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response

TypeinterventionalSponsorLaureate Institute for Brain Research, Inc.Ran2016 to 2022Enrolled121ConditionsGeneralized Anxiety DisorderArmsExposure-based therapy, Behavioral Activation therapy, Computer-based behavioral assessment, Surveys and Interviews, Magnetic resonance imaging (MRI)
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Hannah BergLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Elisabeth AkemanLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Timothy J McDermottLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Kelly T CosgroveLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Namik KirlicLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Ashley ClausenSt. Vincent Hospital, Billings, 1233 N 30th St, Billings, MT 59101, USA.
Mallory CannonLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Hung-Wen YehHealth Services & Outcomes Research, Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO 64108, USA.
Evan WhiteLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Wesley K ThompsonFamily Medicine and Public Health, UC San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA.
Emily M ChoquetteLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Cassandra A Sturycz-TaylorLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Gabe CochranLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Sam RamirezLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Christopher R MartellDepartment of Psychological and Brain Sciences, University of Massachusetts-Amherst, 135 Hicks Way, Amherst, MA 01003, USA.
Kate B Wolitzky-TaylorPsychology, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, 405 Hilgard Avenue, Los Angeles, CA 90077, USA.
Michelle G CraskePsychology, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, 405 Hilgard Avenue, Los Angeles, CA 90077, USA.
James L AbelsonDepartment of Psychiatry, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA.
Martin P PaulusLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Robin L AupperleLaureate Institute for Brain Research, 6655 South Yale Ave., Tulsa, OK 74136, USA.
Laureate Institute for Brain Research · USUniversity of California, Los Angeles · USChildren's Mercy Hospital · USSt Vincent Hospital · USUniversity of California San Diego · USUniversity of Massachusetts Amherst · USUniversity of Michigan · US

Funding

An Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome in Anxiety and DepressionR01MH123691 · NIMH · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI AUPPERLE, ROBIN L · 2020 to 2024
$2.6M
Approach-Avoidance Conflict-a multi-level predictor for exposure therapy responseK23MH108707 · NIMH · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI AUPPERLE, ROBIN L · 2016 to 2020
$976k
Self-regulation of Prefrontal Cortex during Emotional Cognitive ControlF31MH122090 · NIMH · UNIVERSITY OF TULSA · PI MCDERMOTT, TIMOTHY · 2020 to 2022
$102k
The Role of Social and Neural Connectedness in Predicting Neurodevelopmental Functioning in AdolescenceF31HD103340 · NICHD · UNIVERSITY OF TULSA · PI COSGROVE, KELLY THERESA · 2020 to 2021
$90k
NICHD NIH HHS F31 HD103340NIMH NIH HHS F31 MH122090NIMH NIH HHS K23 MH108707NIMH NIH HHS R01 MH123691
6 · The paper itself

Abstract

Objective: Exposure-based therapy (EXP) and behavioral activation (BA) are empirically-supported behavioral intervention techniques that target avoidance and approach behavior to alleviate symptoms. Although EXP is an established treatment for generalized anxiety disorder (GAD), the effectiveness of BA for GAD has not been directly tested or compared with that of EXP. This study examined the efficacy of EXP and BA for adults with GAD. Method: In a randomized clinical trial (clinicaltrials.gov: NCT02807480) with partial blinding in Tulsa, OK, 102 adults with GAD were allocated to manualized, 10-session EXP or BA between April 2016-April 2021. Primary analyses were intention-to-treat and included the 94 (46 EXP, 48 BA) participants who started treatment. The GAD-7 self-report scale was the primary outcome measure. Results: Similar GAD-7 declines were observed at post-treatment for EXP ( Conclusions: BA and EXP are both effective in treating GAD, and BA may confer greater benefit during treatment. Future research is warranted to inform personalized treatment approaches.

Indexed as

Behavior therapyClinical trialsExposure therapyGeneralized anxiety disorder

Identifiers

PMID38384390
PMCPMC10881118
OpenAlexW4380201824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.